BioAdaptives, Inc. Files 8-K Report

Ticker: BDPT · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1575142

Bioadaptives, INC. 8-K Filing Summary
FieldDetail
CompanyBioadaptives, INC. (BDPT)
Form Type8-K
Filed DateMar 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure

Related Tickers: BDPT

TL;DR

BIOADAPTIVES (BDPT) filed an 8-K on March 13th, standard disclosure.

AI Summary

BioAdaptives, Inc. filed an 8-K on March 18, 2025, reporting an event on March 13, 2025. The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, formerly known as APEX 8 Inc., is incorporated in Delaware and headquartered in Las Vegas, Nevada.

Why It Matters

This filing indicates a significant corporate event or update for BioAdaptives, Inc., requiring disclosure to the public and investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K disclosure and does not contain information about significant financial changes, mergers, or executive departures.

Key Players & Entities

FAQ

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported is dated March 13, 2025.

What is the full legal name of the company filing this report?

The full legal name of the company is BIOADAPTIVES, INC.

What was the company's former name?

The company's former name was APEX 8 Inc.

In which state was BioAdaptives, Inc. incorporated?

BioAdaptives, Inc. was incorporated in Delaware.

What is the principal executive office address of BioAdaptives, Inc.?

The principal executive office is located at 2620 Regatta Drive, Suite 102, Las Vegas, Nevada 89128.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding BIOADAPTIVES, INC. (BDPT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing